Sep 6, 2022 11:28 am EDT bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
Dec 6, 2021 11:00 am EST bioAffinity Technologies Presents its Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
Oct 14, 2021 11:00 am EDT bioAffinity Technologies Announces Xavier T. Reveles Promoted to Vice President of Operations
Sep 23, 2021 11:00 am EDT bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
Sep 14, 2021 11:00 am EDT bioAffinity Technologies Announces Precision Pathology Services’ Validation of Novel Non-Invasive Early Lung Cancer Test
Aug 12, 2021 11:00 am EDT bioAffinity Technologies Publishes Sputum Processing and Innovative High-Throughput Analysis Methods
Jun 23, 2021 11:00 am EDT bioAffinity Technologies Presents Scientific Discoveries Advancing Cancer Therapeutics and Diagnostics at Two Global Conferences
Mar 3, 2021 11:00 am EST Leading Cell Biology Journal Publishes bioAffinity Technologies’ Groundbreaking Research on Porphyrins
Feb 4, 2021 10:00 am EST bioAffinity Technologies Executes Agreement with Fosun Long March to Evaluate CyPath® Lung for Commercialization in China
